Looking to list your PhD opportunities? Log in here.
About the Project
V(D)J recombination is essential to produce an effective adaptive immune system but since the reaction involves the breakage and rejoining of DNA, it is highly dangerous and errors have long been thought to lead to leukaemias and lymphomas. Recently, we uncovered a novel aberrant recombination reaction, named "cut-and-run" where the recombination by-product, in complex with the recombinase, triggers a series of double strand breaks throughout the genome. Crucially, these breaks correspond to some of those found in patients with Acute Lymphoblastic Leukaemia (ALL), suggesting that cut-and-run could play an important role in the development of ALL. This project aims to further investigate the cut-and-run reaction and whether it truly plays a role in the development of ALL with the longer term aim of developing novel cut-and-run inhibitors.
The four specific objectives are to:
1) Determine if the genomic breakpoints identified in ALL cells are bona fide recombinase targets.
2) Determine if the recombination by-product is present in ALL patient samples and test how long the by-product persists in these cells.
3) Test if the recombination by-product can really lead to disease progression using a model system based on ALL-progenitor cells.
4) Begin analysis of the recombination by-product/recombinase complex for longer term structural studies.
These studies will thus investigate a new mechanism by which a very frequent group of cancers is caused. In the longer term, it is hoped that these studies can help in the understanding of the risk factors, as well as the development of inhibitors, of these devastating diseases.
These studies will provide training in a broad range of modern techniques, including molecular biology, biochemistry, bioinformatics and preliminary structural biology analyses.
Funding Notes
View Website
View Website
and
View Website
Possible relevant scholarships.
View Website
View Website
References
Smith AL, Scott JNF and Boyes J (2019). The ESC: The Dangerous By-product of V(D)J Recombination. Front. Immunol. 10:1572. doi: 10.3389/fimmu.2019.01572
Thwaites DT, Carter C, Lawless D, Savic S, Boyes JM. (2019) A novel RAG1 mutation reveals a critical in vivo role for HMGB1/2 during V(D)J recombination. Blood 133, 820-829. doi: 10.1182/blood-2018-07-866939.
Scott JN, Kupinski AP, Kirkham CM, Tuma R, Boyes J. (2014) TALE proteins bind to both active and inactive chromatin. Biochem J. 458:153-8. doi: 10.1042/BJ20131327.
Bevington, S., and Boyes, J., (2013) Transcription-coupled Eviction of histones H2A/H2B governs V(D)J recombination. EMBO J. 32:1381-92
How good is research at University of Leeds in Biological Sciences?
Research output data provided by the Research Excellence Framework (REF)
Click here to see the results for all UK universitiesEmail Now
Why not add a message here
The information you submit to University of Leeds will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.

Search suggestions
Based on your current searches we recommend the following search filters.
Check out our other PhDs in Leeds, United Kingdom
Check out our other PhDs in United Kingdom
Start a New search with our database of over 4,000 PhDs

PhD suggestions
Based on your current search criteria we thought you might be interested in these.
A functional proteomic approach to reveal how receptor tyrosine kinases trafficking specifies cancer cell responses
The University of Manchester
Determining how immune responses are regulated at mucosal surfaces
The University of Manchester
Epigenetics of the germline: how maternal cues get passed to the next generation
University of Warwick